Care365.caAnytime,AnywhereTeam sign in
Menu
Book with Care365

MMR & MMRV

MMR and MMRV (measles, mumps, rubella, chickenpox)

M-M-R II · PRIORIX · PRIORIX-TETRA · PROQUAD

Two doses for children and adolescents; one or two for susceptible adults. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.

How many doses do I need? →

Products authorized in Canada

Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.

ProductDINWhat it isPresentation and ageOfficial information
M-M-R II
Live vaccine
00466085Measles, mumps, rubella — live attenuated0.5 mL · powder for solution · subcutaneous or intramuscular · 12 months and older
PRIORIX
Live vaccine
02239208Measles, mumps, rubella — live attenuated0.5 mL · powder for solution · subcutaneous or intramuscular · 12 months and older
PRIORIX-TETRA
Live vaccine
02297884Measles, mumps, rubella, varicella — live attenuated0.5 mL · powder for solution · subcutaneous or intramuscular · 12 months to 12 years
PROQUAD
Live vaccine
02399229Measles, mumps, rubella, varicella — live attenuated0.5 mL · powder for solution · subcutaneous · 12 months to 12 years

Pregnancy and breastfeeding

Pregnancy

Generally contraindicated: MMR and MMRV are live vaccines. Avoid pregnancy for 4 weeks after a dose. Vaccination may be considered during a measles or rubella outbreak.

Breastfeeding

Recommended if not immune.

Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.

How many doses

The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.

ScheduleDosesWho it is forProducts
MMR — children and adolescents (12 months to 17 years), two doses
Dose 1 at 12 to 15 months and dose 2 at 18 months or later; susceptible adolescents get two doses at least 4 weeks apart.
2 dosesTwo doses of measles-containing vaccine. Children: first dose at 12 to 15 months of age, second at 18 months or any time after, but no later than around school entry. Susceptible adolescents 13 to 17 years: 2 doses of MMR at least 4 weeks apart. Infants 6 to 11 months travelling to high-risk areas may receive an early dose that does not count toward the series.M-M-R II, PRIORIX
MMR — adult born in 1970 or later without immunity, one dose
One dose for susceptible adults 18 and older born in or after 1970.
1 doseAdults born in 1970 or later without documented immunity receive one dose of MMR. Health care workers, travellers, military personnel and post-secondary students should receive two doses instead. Adults born before 1970 are generally presumed immune.M-M-R II, PRIORIX
MMR — health care workers, travellers, students, military: two doses
Two doses at least 4 weeks apart for adults at higher exposure risk.
2 dosesFor susceptible adults at higher measles exposure risk (health care workers, travellers, post-secondary students, military): two doses of MMR with a minimum interval of 4 weeks.M-M-R II, PRIORIX
MMRV — children, two doses (12 months to 12 years)
Dose 1 at 12 to 15 months and dose 2 at 18 months or later; not used at 13 years and older.
2 dosesCombined measles-mumps-rubella-varicella vaccine is authorized for healthy children 12 months to less than 13 years. First dose at 12 to 15 months, second at 18 months or later but before school entry. Minimum interval 4 weeks (3 months recommended for the varicella component). Febrile seizures are slightly more common after a first dose of MMRV than separate MMR and varicella vaccines in 12 to 23 month olds.PRIORIX-TETRA, PROQUAD

Open the dose planner

Sources

Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.